Hims & Hers Health (HIMS) Consolidated Net Income (2019 - 2026)

Hims & Hers Health (HIMS) reported Consolidated Net Income of -$92.1 million for Q1 2026, down 286.15% on a YoY basis from $49.5 million in Q1 2025, and down 547.14% sequentially from $20.6 million in Q4 2025.

Hims & Hers Health (HIMS) Consolidated Net Income (2019 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 8 years of Consolidated Net Income data on file, last reported at -$92.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Consolidated Net Income fell 286.15% year-over-year to -$92.1 million; the trailing twelve-month figure through Mar 2026 stood at -$13.2 million (down 108.05% YoY), and the FY2025 full-year result was $128.4 million, up 1.85% from the prior year.
  • Consolidated Net Income retreated to -$92.1 million in Q1 2026, from $20.6 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $75.6 million in Q3 2024 to a low of -$92.1 million in Q1 2026.
  • A 5-year average of $4.3 million and a median of $1.2 million in 2023 frame the typical range for Consolidated Net Income.
  • Across the five-year window, Consolidated Net Income soared 1990.36% in 2024 and slumped 286.15% in 2026, its largest moves.
  • Tracing HIMS's Consolidated Net Income over 5 years: stood at -$10.9 million in 2022, then surged by 111.41% to $1.2 million in 2023, then soared by 1990.36% to $26.0 million in 2024, then dropped by 20.84% to $20.6 million in 2025, then slumped by 547.14% to -$92.1 million in 2026.
  • Business Quant data shows HIMS's Consolidated Net Income at -$92.1 million in Q1 2026, $20.6 million in Q4 2025, and $15.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 274.90 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 57.00 Mn
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn -92.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -92.12 Mn
Dec 31, 2025 20.60 Mn
Sep 30, 2025 15.77 Mn
Jun 30, 2025 42.51 Mn
Mar 31, 2025 49.49 Mn
Dec 31, 2024 26.03 Mn
Sep 30, 2024 75.59 Mn
Jun 30, 2024 13.30 Mn
Mar 31, 2024 11.13 Mn
Dec 31, 2023 1.25 Mn
Sep 30, 2023 -7.57 Mn
Jun 30, 2023 -7.16 Mn
Mar 31, 2023 -10.07 Mn
Dec 31, 2022 -10.91 Mn
Sep 30, 2022 -18.84 Mn
Jun 30, 2022 -19.68 Mn
Mar 31, 2022 -16.25 Mn
Dec 31, 2021 -31.16 Mn
Sep 30, 2021 -15.94 Mn
Jun 30, 2021 -9.15 Mn